473 related articles for article (PubMed ID: 18383165)
1. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
[TBL] [Abstract][Full Text] [Related]
2. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
[TBL] [Abstract][Full Text] [Related]
3. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
4. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
Olabode JO; Shokunbi WA
West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
[TBL] [Abstract][Full Text] [Related]
5. Quantification of analgesic use in children with sickle cell disease.
Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
7. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
8. Day hospital versus inpatient management: An economic initiative of a pediatric center, examplified on uncomplicated vaso-occlusive crises of children with sickle cell disease.
Imbach P
Pediatr Blood Cancer; 2008 Sep; 51(3):317. PubMed ID: 18383149
[No Abstract] [Full Text] [Related]
9. Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease.
Zempsky WT; Loiselle KA; McKay K; Blake GL; Hagstrom JN; Schechter NL; Kain ZN
Pediatr Blood Cancer; 2008 Aug; 51(2):265-8. PubMed ID: 18386784
[TBL] [Abstract][Full Text] [Related]
10. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.
Morrissey LK; Shea JO; Kalish LA; Weiner DL; Branowicki P; Heeney MM
Pediatr Blood Cancer; 2009 Mar; 52(3):369-72. PubMed ID: 19023890
[TBL] [Abstract][Full Text] [Related]
12. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
[TBL] [Abstract][Full Text] [Related]
13. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
Panepinto JA; Brousseau DC; Hillery CA; Scott JP
Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
[TBL] [Abstract][Full Text] [Related]
14. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
Akar NA; Adekile A
Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
Stallworth JR; Jerrell JM; Tripathi A
Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
[TBL] [Abstract][Full Text] [Related]
16. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
Allen Liles E; Kirsch J; Gilchrist M; Adem M
Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
[TBL] [Abstract][Full Text] [Related]
17. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
Yale SH; Nagib N; Guthrie T
Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
[TBL] [Abstract][Full Text] [Related]
18. Impact of environmental tobacco smoke on children with sickle cell disease.
West DC; Romano PS; Azari R; Rudominer A; Holman M; Sandhu S
Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1197-201. PubMed ID: 14662575
[TBL] [Abstract][Full Text] [Related]
19. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
Wilimas JA; Flynn PM; Harris S; Day SW; Smith R; Chesney PJ; Rodman JH; Eguiguren JM; Fairclough DL; Wang WC
N Engl J Med; 1993 Aug; 329(7):472-6. PubMed ID: 8332152
[TBL] [Abstract][Full Text] [Related]
20. Emergency department management of acute pain episodes in sickle cell disease.
Tanabe P; Myers R; Zosel A; Brice J; Ansari AH; Evans J; Martinovich Z; Todd KH; Paice JA
Acad Emerg Med; 2007 May; 14(5):419-25. PubMed ID: 17389246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
